🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/04/2010 | 58,02 | 58,13 | 56,95 | 57,07 | -1,18% | 2,03% | 673.400 |
| 09/04/2010 | 58,36 | 58,60 | 57,56 | 57,75 | -1,27% | 1,78% | 429.400 |
| 08/04/2010 | 57,37 | 58,69 | 57,31 | 58,49 | +1,51% | 2,41% | 391.600 |
| 07/04/2010 | 58,30 | 58,72 | 57,35 | 57,62 | -0,93% | 2,35% | 518.900 |
| 06/04/2010 | 56,04 | 58,42 | 55,98 | 58,16 | +3,29% | 4,35% | 849.300 |
| 05/04/2010 | 55,45 | 56,89 | 55,18 | 56,31 | +2,08% | 3,08% | 998.500 |
| 01/04/2010 | 55,13 | 55,68 | 53,55 | 55,16 | -0,31% | 3,86% | 642.900 |
| 31/03/2010 | 55,98 | 56,32 | 55,30 | 55,33 | -1,07% | 1,82% | 863.400 |
| 30/03/2010 | 56,36 | 56,70 | 55,65 | 55,93 | -0,85% | 1,86% | 445.900 |
| 29/03/2010 | 56,12 | 56,95 | 55,73 | 56,41 | +1,15% | 2,17% | 569.300 |
| 26/03/2010 | 56,00 | 57,60 | 55,70 | 55,77 | -0,39% | 3,39% | 586.800 |
| 25/03/2010 | 56,37 | 56,92 | 55,90 | 55,99 | -0,57% | 1,81% | 485.500 |
| 24/03/2010 | 56,62 | 57,23 | 56,26 | 56,31 | -1,05% | 1,71% | 414.200 |
| 23/03/2010 | 56,54 | 57,42 | 56,21 | 56,91 | +0,41% | 2,14% | 316.500 |
| 22/03/2010 | 56,94 | 57,11 | 56,09 | 56,68 | -0,53% | 1,79% | 539.400 |
| 19/03/2010 | 57,35 | 57,69 | 56,92 | 56,98 | -0,23% | 1,34% | 590.200 |
| 18/03/2010 | 56,58 | 57,35 | 55,97 | 57,11 | +0,56% | 2,44% | 570.200 |
| 17/03/2010 | 57,14 | 57,87 | 56,54 | 56,79 | -0,33% | 2,33% | 493.800 |
| 16/03/2010 | 57,05 | 57,39 | 56,62 | 56,98 | -0,30% | 1,35% | 640.100 |
| 15/03/2010 | 58,36 | 58,53 | 55,90 | 57,15 | -2,74% | 4,51% | 1.171.900 |
| 12/03/2010 | 59,39 | 59,39 | 58,43 | 58,76 | -1,13% | 1,62% | 665.500 |
| 11/03/2010 | 59,38 | 59,91 | 59,00 | 59,43 | -0,40% | 1,53% | 330.100 |
| 10/03/2010 | 59,10 | 59,88 | 59,10 | 59,67 | +0,96% | 1,32% | 399.400 |
| 09/03/2010 | 59,21 | 59,85 | 58,83 | 59,10 | -0,34% | 1,72% | 379.900 |
| 08/03/2010 | 58,52 | 59,30 | 58,00 | 59,30 | +1,44% | 2,22% | 1.202.900 |
| 05/03/2010 | 57,99 | 58,68 | 57,97 | 58,46 | +1,55% | 1,22% | 204.600 |
| 04/03/2010 | 58,26 | 58,26 | 56,87 | 57,57 | -1,74% | 2,39% | 580.300 |
| 03/03/2010 | 58,87 | 59,22 | 58,47 | 58,59 | +0,02% | 1,27% | 329.000 |
| 02/03/2010 | 58,71 | 59,13 | 58,40 | 58,58 | +0,17% | 1,24% | 1.071.000 |
| 01/03/2010 | 57,39 | 58,72 | 56,60 | 58,48 | +1,86% | 3,69% | 813.400 |